OBIO vs SRPT · rev $198.0K vs rev $1.13B
Orchestra BioMed Holdings Inc. (OBIO) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
Orchestra BioMed Holdings Inc. (OBIO) is a biotechnology company listed on NASDAQ.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported OBIO revenue for 2026-06-30 was $198.0K. Net income was -$44.4M. Revenue was up 80.0% from 2026-03-31 to 2026-06-30. OBIO currently screens at market cap $231.7M.
Latest reported SRPT revenue for 2026-06-30 was $1.13B. Net income was $326.1M. Revenue was up 54.9% from 2026-03-31 to 2026-06-30. SRPT currently screens at market cap $2.34B.
OBIO currently screens at market cap $231.7M. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the OBIO and SRPT stock pages for the full models.
Not investment advice.